Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

28-year Johnson & Johnson veteran decides to call it a day:

This article was originally published in Clinica

Executive Summary

President and vice-chairman of the board of directors of Johnson & Johnson James Lenehan has said that he will retire from active board duties on February 1 2004, after 28 years with the company. He joined J&J's McNeil Consumer Products subsidiary in 1976, and rose up to become worldwide president of the medical devices and consumer products division in 1999. His board vice-chairmanship also conferred divisional responsibility for consumer products. He became president two years ago. Medtech and consumer products will now report directly to J&J chairman and CEO William Weldon. Mr Lenehan will remain with the company until June 30 for a transitional period.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel